Exchange Commission acting as Capital Market Supervisory Board by virtue of Section 6 of the Derivatives Act (No.2) B.E. 2551 (2008) hereby issues the following regulations: Clause 1. This Notification shall
for the 3rd Quarter of 2017 Ending 30 September 2017 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 5
October 11, 2019 Re: Clarification of the operating results of company and its subsidiaries for the nine month periods ended September 30, 2018 To: President The Stock Exchange of Thailand K.C
% Y-o-Y and an increase of 1.5% Q-o-Q. The Y-o-Y decrease was primarily attributed to the reduction in gross profit rate, the substantial effect of a change in foreign currency exchange rates and an
the 2nd Quarter of 2017 Ending June 30, 2017 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4/2017
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
May 9, 2018 Re : Operating Performance for Q1/2018 To : Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated revenue from sales of
- Translation - Ref : LPH/SET 2018/014 May 11, 2018 Subject : Clarification on the Operating Results for the three-month period ended March 31, 2017 (Q1/2017) To : President The Stock Exchange of
- Translation – No. M06/001/19 February 25, 2019 Subject Clarification on Y2018 Company Performance To The President of the Stock Exchange of Thailand Reference MDX Public Company Limited and its
No.SN.LK.63.02.0003 February 20 , 2020 Subject: Management Discussion and Analysis for the year ended 31 December 2019 Attention: The President, The Stock Exchange of Thailand Indara Insurance Public